Mar 30, 2020 3:47 PM
BACK TO TOP
KSE100
28,023.39
-86.18
(-0.31%)
ALLSHR
20,322.54
-162.69
(-0.79%)
KSE30
12,285.08
-35.16
(-0.29%)
KMI30
42,943.13
-112.11
(-0.26%)
BKTi
9,731.73
-99.12
(-1.01%)
OGTi
9,456.32
-427.76
(-4.33%)
KMIALLSHR
13,173.22
-56.10
(-0.42%)
UPP9
8,871.77
38.44
(0.44%)
NITPGI
6,499.33
-36.67
(-0.56%)
Ferozsons Laboratories Limited
PHARMACEUTICALS
Rs.161.75
0.71
(0.44%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Mar 30, 2020 3:30 PM
REG
FUT
ODL
Open
156.01
High
162.00
Low
155.00
Volume
41,000
CIRCUIT BREAKER
148.96 — 173.12
DAY RANGE
155.00 — 162.00
52-WEEK RANGE
86.87 — 236.00
Ask Price
161.75
Ask Volume
3,000
Bid Price
0.00
Bid Volume
0
LDCP
161.04
VAR
12.65
HAIRCUT
16.50
P/E Ratio (TTM)
16.97
1-Year Change *
-20.20%
YTD Change *
-22.84%
Open
161.00
High
161.00
Low
160.00
Close
161.00
Change
-0.02%
LDCP
161.04
Volume
31
Total Trades
5
CIRCUIT BREAKER
144.94 — 177.14
DAY RANGE
160.00 — 161.00
Ask Price
164.99
Ask Volume
1
Bid Price
152.00
Bid Volume
44
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was subsequently converted into a public limited company. The Company is primarily engaged in the imports, manufacture and sale of pharmaceuticals products and medical devices.

KEY PEOPLE
Mrs. Akhter Khalid WaheedChairman
Mr. Osman Khalid WaheedCEO
Mr. Syed Ghausuddin SaifCompany Secretary
ADDRESS

Ferozsons Laboratories Limited 197-A, The Mall Rawalpindi, Pakistan.

WEBSITE

www.ferozsons-labs.com

REGISTRAR

CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
4,882,721.53
Shares
30,186,841
Free Float
12,074,736
Free Float
40.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Feb 28, 2020Transmission of Quarterly Report for the Period Ended 2019-12-31 View   PDF
Feb 28, 2020Financial Results for the Quarter Ended 2019-12-31 View   PDF
Oct 30, 2019Transmission of Quarterly Report for the Period Ended 30-09-2019 View   PDF
Oct 25, 2019Financial Results for the Quarter Ended 2019-09-30 View   PDF
Oct 4, 2019Transmission of Annual Report for the Year Ended 30-06-2019 View   PDF
Sep 23, 2019Financial Results for the Year Ended 2019-06-30 View   PDF
Sep 23, 2019Financial Results for the Quarter Ended 2019-06-30 View   PDF
Apr 30, 2019Transmission of Quarterly Report for the Period Ended 31-03-2019 View   PDF
Apr 17, 2019Financial Results for the Quarter Ended 2019-03-31 View   PDF
Feb 28, 2019Transmission of Quarterly Report for the Period Ended 2018-12-31 View   PDF
DateTitleDocument
Feb 21, 2020Board Meeting View   
Oct 31, 2019Certified Copies of Resolutions passed in the Annual General Meeting View   PDF
Oct 18, 2019Board Meeting View   
Oct 2, 2019Notice of Annual General Meeting View   PDF
Sep 13, 2019Board Meeting View   
Apr 11, 2019Board Meeting View   
Apr 10, 2019Board Meeting View   
Feb 15, 2019Board Meeting View   
Oct 19, 2018Board Meeting View   
Oct 5, 2018Notice of Annual General Meeting View   PDF
DateTitleDocument
Mar 4, 2020Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jan 17, 2020Material Information View   
Nov 18, 2019Corporate Briefing Session (CBS) View   PDF
Nov 13, 2019Credit of Final Cash Dividend View   
Jul 26, 2019Change of Chief Financial Officer View   
Mar 15, 2019Credit of Interim Cash Dividend View   
Feb 28, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Feb 26, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Nov 9, 2018Credit of Final Cash Dividend View   
Sep 6, 2018Change in Beneficial Ownership of Director View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales5,180,8044,459,3234,311,44210,186,496
Profit after Taxation251,04695,406393,6652,104,486
EPS8.323.1613.0469.72
Q2 2020Q1 2020Q3 2019Q2 2019
Sales1,334,3271,188,8281,242,0281,297,406
Profit after Taxation95,12683,00213,13276,952
EPS3.152.750.432.55
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)39.4935.2041.2140.34
Net Profit Margin (%)4.852.149.1320.66
EPS Growth (%)163.29(75.77)(81.30)181.13
PEG0.08(0.81)(0.36)0.08

Payouts

DateFinancial ResultsDetailsBook Closure
September 23, 2019 2:47 PM30/06/2019(YR) 40%(F) (D) 18/10/2019 - 25/10/2019
February 25, 2019 12:50 PM31/12/2018(HYR) 20% (i) (D) 08/03/2019 - 14/03/2019
September 25, 2018 3:08 PM30/06/2018(YR) 20% (D) 20/10/2018 - 27/10/2018
August 30, 2017 3:38 PM30/06/2017(YR) 40% (D) M /10/2017 - 18/10/2017
January 30, 2017 3:47 PM31/12/2016(HYR) 30%(I) (D) 11/02/2017 - 19/02/2017
August 30, 2016 10:16 AM30/06/2016(YR) 120% (F) (D) 11/10/2016 - 20/10/2016
January 26, 2016 9:54 AM31/12/2015(HYR) 100%(I) (D) 20/02/2016 - 26/02/2016
August 31, 2015 9:51 AM30/06/2015(YR) 150% (D) 13/10/2015 - 19/10/2015
August 31, 2015 9:51 AM30/06/2015(YR) 150% (D) 13/10/2015 - 19/10/2015
February 16, 2015 3:52 PM31/12/2015(HYR) 40%(I) (D) 13/03/2015 - 20/03/2015

Financial Reports